These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38241751)

  • 1. Responsively Degradable Nanoarmor-Assisted Super Resistance and Stable Colonization of Probiotics for Enhanced Inflammation-Targeted Delivery.
    Zhu L; Yu T; Wang W; Xu T; Geng W; Li N; Zan X
    Adv Mater; 2024 May; 36(18):e2308728. PubMed ID: 38241751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea.
    Pan J; Gong G; Wang Q; Shang J; He Y; Catania C; Birnbaum D; Li Y; Jia Z; Zhang Y; Joshi NS; Guo J
    Nat Commun; 2022 Apr; 13(1):2117. PubMed ID: 35440537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Lactic Acid Probiotic Bacteria in IBD.
    Vemuri R; Gundamaraju R; Eri R
    Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics.
    Celiberto LS; Pinto RA; Rossi EA; Vallance BA; Cavallini DCU
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The single-cell modification strategies for probiotics delivery in inflammatory bowel disease: A review.
    Han M; Lei W; Liang J; Li H; Hou M; Gao Z
    Carbohydr Polym; 2024 Jan; 324():121472. PubMed ID: 37985038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model.
    Xu L; Liu B; Huang L; Li Z; Cheng Y; Tian Y; Pan G; Li H; Xu Y; Wu W; Cui Z; Xie L
    Microbiol Spectr; 2022 Aug; 10(4):e0065722. PubMed ID: 35730951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
    Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
    Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis.
    Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM
    Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional Support and Probiotics as a Potential Treatment of IBD.
    Tarasiuk A; Eibl G
    Curr Drug Targets; 2020; 21(14):1417-1427. PubMed ID: 32364071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the gut microbiota in inflammatory bowel diseases: where are we?
    Benech N; Sokol H
    Curr Opin Microbiol; 2023 Aug; 74():102319. PubMed ID: 37062174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice.
    Zhu Y; Xu Y; Wang X; Rao L; Yan X; Gao R; Shen T; Zhou Y; Kong C; Zhou L
    Front Cell Infect Microbiol; 2022; 12():886061. PubMed ID: 35782138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota.
    Huang QX; Liang JL; Yang CH; Li K; Niu MT; Fan JX; Zhang XZ
    Biomaterials; 2023 Oct; 301():122274. PubMed ID: 37586233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.